Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This phase II trial studies the how well fractionated gemtuzumab ozogamicin works in treating measurable residual disease in patients with acute myeloid leukemia. Gemtuzumab ozogamicin is a monoclonal antibody, called gemtuzumab, linked to a chemotherapy drug, called ozogamicin. Gemtuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as CD33 receptors, and delivers a chemotherapy known as calicheamicin to kill them.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wcześniejsza diagnoza ostrej białaczki szpikowej postawiona według światowych standardów
- •Chorobę w stadium remisji (ustępowania) albo prawie całkowitego ustępowania - małe pozostałości nowotworu w szpiku
- •Ukończone co najmniej jedno leczenie chemioterapią przed wpisaniem do badania
- •Wiek co najmniej 18 lat
- •Ogólny stan zdrowotny pozwalający na leczenie
- •Komórki białaczki muszą mieć białko CD33 na swojej powierzchni
- •Prawidłowe wyniki krwi: kreatynina, bilirubina i enzymy wątroby poniżej określonych limitów
- •Kobieta w wieku rozrodczym musi mieć ujemny test ciąży
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 13, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Fred Hutchinson Cancer Center/University of Washington Cancer Consortium
Seattle, United States
Trial contact
Mary-Elizabeth Percival
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.